Recent Security Class Actions

On July 28, 2025, Lockheed Martin Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Lockheed Martin securities between January 23, 2024 and July 21, 2025, inclusive (the “Class Period”).

On July 28, 2025, Sable Offshore Corp. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded Sable Offshore securities between May 19, 2025 and June 3, 2025, inclusive (the “Class Period”), and/or pursuant and/or traceable to the Company’s May 21, 2025 secondary public offering (the “SPO”).

On July 25, 2025, Flywire Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired Flywire securities between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”).

On July 24, 2025, Fiserv, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Fiserv common stock between July 24, 2024 and July 22, 2025, inclusive (the “Class Period”).

On July 24, 2025, Replimune Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Massachusetts on behalf of investors who purchased or otherwise
acquired publicly traded Replimune securities between November 22, 2024 and July 21, 2025, inclusive (the “Class Period”).

On July 23, 2025, Luminar Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired Luminar securities between March 20, 2025, and May 14, 2025, inclusive (the “Class Period”).

On July 22, 2025, RxSight, Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired RxSight securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).

On July 21, 2025, Alto Neuroscience, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024 (the “IPO” or “Offering”); and/or (b) Alto
securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”).

On July 18, 2025, Neogen Corporation was sued for violations of the federal securities laws in the United States District Court for the Western District of Michigan on behalf of all purchasers of Neogen common stock from January 5, 2023 through June 3, 2025, inclusive (the “Class Period”).

On July 17, 2025, Capricor Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Capricor securities between October 9, 2024 and July 10, 2025, inclusive (the “Class Period”).